Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Encouraging results reported for Cel-Sci's Multikine

June 11, 1998

Immunex's CD40 Ligand enters phase I

June 10, 1998

Initiation of late-stage Avicine clinical trial

June 9, 1998

Genzyme Molecular Oncology and Dana-Farber agreement for fusion cell technology

June 5, 1998

Vical reports initial results from gene-based immunotherapy for prostate cancer

June 4, 1998

FDA advisory committee recommends approval of Ontak for CTCL

June 3, 1998

European Commission clears rituximab for marketing in member countries

June 3, 1998

Idec receives patent protection for radioimmunotherapy

June 3, 1998

Antisoma and Imperial Cancer Research Technology announce collaboration

May 27, 1998

Glaxo Wellcome's 3622W94: phase I trial results presented at ASCO

May 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...